The Product Information File (PIF)
A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.


The Regulation (EC) No 1223/2009 establishes the rules that all cosmetic products made available on the European Union (EU) market must comply with, in order to ensure the functioning of the internal market and a high level of protection of human health.

Only cosmetic products for which a legal or natural person is designated as a “Responsible Person” (RP) can be placed on the EU market. The RP is fully responsible for safety and legal compliance. (see previous post)

According to Article 3 of this Regulation, “a cosmetic product made available on the market shall be safe for human health when used under normal or reasonably foreseeable conditions of use“. In order to demonstrate that a cosmetic product complies with Article 3, the RP must guarantee that the product has undergone a safety assessment and that a Cosmetic Product Safety Report (CPSR) is set up. (see previous post)


The RP needs to compile and keep a Product Information File (PIF) for every cosmetic product placed on the EU market.

The PIF is a dossier of technical documentation that needs to contain the following information:

  • Description of the cosmetic product (which enables the PIF to be clearly attributed to the cosmetic product);
  • The Cosmetic Product Safety Report (CPSR – see previous post);
  • A description of the method of manufacturing and a statement on compliance with Good Manufacturing Practices (GMP);
  • Proof of the effect claimed for the cosmetic product (where justified by the nature or the effect of the product);
  • Data on animal testing performed (by the manufacturer, his agents or suppliers) during the development or safety assessment of the cosmetic product or its ingredients (including animal testing performed to meet legislative/regulatory requirements of third countries).

The PIF needs to be made readily accessible (electronically or in other format) by the RP at his address indicated in the product label. Even if the cosmetic product is available in several EU countries, the PIF is only kept in one single EU address. This address is one of the information that has to be submitted when notifying the product in the Cosmetic Products Notification Portal (CPNP). (see previous post)

The information contained on the PIF should be in a language that can be easily understood by the competent authorities of the Member State in which the RP is keeping the PIF.

The Product Information File has to be kept for a period of 10 years, counting on the date on which the last batch of the cosmetic product was introduced on the EU market. Moreover, the PIF must be always up to date, taking into account relevant information generated after the product is placed on the market (e.g., amendments to Regulation).

Critical Catalyst has a team of qualified EU safety assessors with vast experience in conducting CPSRs and PIFs. For more information, please feel free to contact us at


  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.


cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »
medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »
cosmetic products

European Commission Recommendation on the Definition of Nanomaterial

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. The European Commission has published a new Recommendation to clarify the definition of ‘nanomaterial’. This definition may serve different policy, legislative and research purposes when addressing materials or issues concerning products of nanotechnologies.

Read More »